131 related articles for article (PubMed ID: 38394084)
1.
Tanaka H; Motooka Y; Maeda Y; Sonehara R; Nakamura T; Kajiyama H; Mashimo T; Toyokuni S
Free Radic Res; 2024 Feb; 58(2):130-143. PubMed ID: 38394084
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
[TBL] [Abstract][Full Text] [Related]
3. Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study.
Denis-Laroque L; Drouet Y; Plotton I; Chopin N; Bonadona V; Lornage J; Salle B; Lasset C; Rousset-Jablonski C
Breast; 2021 Oct; 59():239-247. PubMed ID: 34304065
[TBL] [Abstract][Full Text] [Related]
4. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
[TBL] [Abstract][Full Text] [Related]
5. Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study.
Winship AL; Willson C; Hansen KR; Hutt KJ; Hickey M
BMJ Open; 2019 Nov; 9(11):e033810. PubMed ID: 31772111
[TBL] [Abstract][Full Text] [Related]
6. Assessment of ovarian reserve and reproductive outcomes in
Ponce J; Fernandez-Gonzalez S; Calvo I; Climent M; Peñafiel J; Feliubadaló L; Teulé A; Lázaro C; Brunet JM; Candás-Estébanez B; Durán Retamal M
Int J Gynecol Cancer; 2020 Jan; 30(1):83-88. PubMed ID: 31780568
[TBL] [Abstract][Full Text] [Related]
7. Anti-Müllerian Hormone: genetic and environmental effects.
Shahrokhi SZ; Kazerouni F; Ghaffari F
Clin Chim Acta; 2018 Jan; 476():123-129. PubMed ID: 29175649
[TBL] [Abstract][Full Text] [Related]
8. Navigating the body of literature assessing BRCA1/2 mutations and markers of ovarian function: a systematic review and meta-analysis.
Cordeiro Mitchell CN; McGuinness B; Fine E; Kearns WG; Christianson MS; Segars J; Pastore LM
J Assist Reprod Genet; 2020 May; 37(5):1037-1055. PubMed ID: 32212026
[TBL] [Abstract][Full Text] [Related]
9. BRCA1/2 genes mutations, ovarian reserve and female reproductive outcomes: a systematic review of the literature.
Merlino L; Chiné A; Galli C; Piccioni MG
Minerva Ginecol; 2020 Oct; 72(5):339-348. PubMed ID: 32744451
[TBL] [Abstract][Full Text] [Related]
10. Multigenerational and transgenerational effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on ovarian reserve and follicular development through AMH/AMHR2 pathway in adult female rats.
Yu K; Zhang X; Tan X; Ji M; Chen Y; Wan Z; Yu Z
Food Chem Toxicol; 2020 Jun; 140():111309. PubMed ID: 32234510
[TBL] [Abstract][Full Text] [Related]
11. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging.
Turan V; Oktay K
Hum Reprod Update; 2020 Jan; 26(1):43-57. PubMed ID: 31822904
[TBL] [Abstract][Full Text] [Related]
12. Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.
Oktay KH; Bedoschi G; Goldfarb SB; Taylan E; Titus S; Palomaki GE; Cigler T; Robson M; Dickler MN
Fertil Steril; 2020 Jun; 113(6):1251-1260.e1. PubMed ID: 32331767
[TBL] [Abstract][Full Text] [Related]
13. Increased DNA damage and repair deficiency in granulosa cells are associated with ovarian aging in rhesus monkey.
Zhang D; Zhang X; Zeng M; Yuan J; Liu M; Yin Y; Wu X; Keefe DL; Liu L
J Assist Reprod Genet; 2015 Jul; 32(7):1069-78. PubMed ID: 25957622
[TBL] [Abstract][Full Text] [Related]
14. Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans.
Titus S; Li F; Stobezki R; Akula K; Unsal E; Jeong K; Dickler M; Robson M; Moy F; Goswami S; Oktay K
Sci Transl Med; 2013 Feb; 5(172):172ra21. PubMed ID: 23408054
[TBL] [Abstract][Full Text] [Related]
15. Early postnatal methoxychlor exposure inhibits folliculogenesis and stimulates anti-Mullerian hormone production in the rat ovary.
Uzumcu M; Kuhn PE; Marano JE; Armenti AE; Passantino L
J Endocrinol; 2006 Dec; 191(3):549-58. PubMed ID: 17170213
[TBL] [Abstract][Full Text] [Related]
16. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
[TBL] [Abstract][Full Text] [Related]
17. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.
Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I
J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386
[TBL] [Abstract][Full Text] [Related]
18. Accelerated ovarian reserve depletion in female anti-Müllerian hormone knockout mice has no effect on lifetime fertility†.
Guo R; Pankhurst MW
Biol Reprod; 2020 Apr; 102(4):915-922. PubMed ID: 31837140
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 germline mutations may be associated with reduced ovarian reserve.
Wang ET; Pisarska MD; Bresee C; Chen YD; Lester J; Afshar Y; Alexander C; Karlan BY
Fertil Steril; 2014 Dec; 102(6):1723-8. PubMed ID: 25256924
[TBL] [Abstract][Full Text] [Related]
20. Leptin suppresses anti-Mullerian hormone gene expression through the JAK2/STAT3 pathway in luteinized granulosa cells of women undergoing IVF.
Merhi Z; Buyuk E; Berger DS; Zapantis A; Israel DD; Chua S; Jindal S
Hum Reprod; 2013 Jun; 28(6):1661-9. PubMed ID: 23503941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]